Fennec Pharmaceuticals Inc. (FENC)
NASDAQ · Healthcare
Fennec Pharmaceuticals Inc. Total Liabilities 2011–2025
Fennec Pharmaceuticals Inc. annual total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Fennec Pharmaceuticals Inc. total liabilities as of December 31, 2025: 35.1M, a 30.97% decrease year-over-year.
- Fennec Pharmaceuticals Inc. total liabilities for 2025 were 35.1M, a 30.97% decrease from 2024.
- Fennec Pharmaceuticals Inc. total liabilities for 2024 were 50.8M, a 32.04% increase from 2023.
- Fennec Pharmaceuticals Inc. total liabilities for 2023 were 38.5M, a 30.43% increase from 2022.
- Fennec Pharmaceuticals Inc. total liabilities for 2022 were 29.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Fennec Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $35 |
| 2024 | $51 |
| 2023 | $38 |
| 2022 | $30 |
| 2020 | $2 |
| 2019 | $2 |
| 2018 | $2 |
| 2017 | $2 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $2 |
| 2013 | $3 |
| 2012 | $7 |
| 2011 | $5 |
Fennec Pharmaceuticals Inc. Total Liabilities — FAQ
Fennec Pharmaceuticals Inc. (FENC) total liabilities over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FENC's total liabilities history?
The chart and table above show Fennec Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.